Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent P792 in a nonreperfused porcine infarction model

Investigative Radiology

Volumn 42, Issue 4, 2007, Pages 248-255

  Peukert, Daniel ^a   Kaufels, Nicola ^a   Laule, Michael ^a   Schnorr, Jörg ^a   Carme, Sabin ^b   Farr, Thomas ^a   Schönenberger, Eva ^c   Taupitz, Matthias ^a   Hamm, Bernd ^a   Dewey, Marc ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Laboratoire Guerbet   (France)

^c LEIBNIZ INSTITUT IM FORSCHUNGSVERBUND BERLIN E V   (Germany)

Author keywords

Contrast agent; MR imaging; Myocardial infarction; Perfusion; Viability

Indexed keywords

CONTRAST MEDIUM; GADOMELITOL; GADOTERIC ACID; MICROSPHERE; TRIPHENYLTETRAZOLIUM;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXPERIMENTAL MODEL; GOLD STANDARD; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGING; MEDICAL INSTRUMENTATION; MINIPIG; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; STEADY STATE;

EID: 33947112405     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000258059.82552.55     Document Type: Article

References (37)

1. Fox CS, Evans JC, Larson MG, et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 2004;110:522-527.
2. Saeed M, Wendland MF, Szolar D, et al. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J. 1996;132:921-932.
3. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
4. Mahrholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J. 2002;23:602-619.
5. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432-437.
6. Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318-3326.
7. Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging. 1999;15:453-464.
8. Maskali F, Ayalew A, Marie PY, et al. Changes in first-pass interstitial kinetics of DTPA in myocardium submitted to low-flow ischemia. Invest Radiol. 2005;40:766-772.
9. Huber ME, Paetsch I, Schnackenburg B, et al. Performance of a new gadolinium-based intravascular contrast agent in free-breathing inversion-recovery 3D coronary MRA. Magn Reson Med. 2003;49:115-121.
10. Li D, Zheng J, Bae KT, et al. Contrast-enhanced magnetic resonance imaging of the coronary arteries. A review. Invest Radiol. 1998;33:578-586.
11. Corot C, Violas X, Robert P, et al. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. Invest Radiol. 2000;35:213-218.
12. Corot C, Violas X, Robert P, et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol. 2003;38:311-319.
13. Taupitz M, Schnorr J, Wagner S, et al. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792. Magn Reson Med. 2001;46:932-938.
14. Taupitz M, Schnorr J, Wagner S, et al. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. Radiology. 2002;222:120-126.
15. Schnorr J, Wagner S, Ebert W, et al. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs]-. Rofo. 2003;175:822-829.
16. Steger-Hartmann T, Graham PB, Muller S, et al. Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography. Invest Radiol. 2006;41:449-459.
17. Dewey M, Kaufels N, Laule M, et al. Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent. Invest Radiol. 2004;39:498-505.
18. Bjornerud A, Johansson LO, Briley-Saebo K, et al. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange. Magn Reson Med. 2002;47:461-471.
19. Port M, Corot C, Rousseaux O, et al. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. Magma. 2001;12:121-127.
20. Mandry D, Pedersen M, Odille F, et al. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in Sprague-Dawley rats. Invest Radiol. 2005;40:295-305.
21. Port M, Corot C, Violas X, et al. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol. 2005;40:565-573.
22. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36:1985-1991.
23. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593-600.
24. Schreiber WG, Schmitt M, Kalden P, et al. Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. J Magn Reson Imaging. 2002;16:641-652.
25. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215-223.
26. Bland JM, Altman DJ. Regression analysis. Lancet. 1986;1:908-909.
27. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.
28. Li D, Dolan RP, Walovitch RC, et al. Three-dimensional MRI of coronary arteries using an intravascular contrast agent. Magn Reson Med. 1998;39:1014-1018.
29. Dewey M, Kaufels N, Laule M, et al. Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium. Magn Reson Med. 2004;51:703-709.
30. Gerber BL, Bluemke DA, Chin BB, et al. Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology. 2002;225:104-112.
31. Kraitchman DL, Chin BB, Heldman AW, et al. MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325. J Magn Reson Imaging. 2002;15:149-158.
32. Zheng J, Li D, Maggioni F, et al. Single-session magnetic resonance coronary angiography and myocardial perfusion imaging using the new blood pool compound B-22956 (gadocoletic acid): initial experience in a porcine model of coronary artery disease. Invest Radiol. 2005;40:604-613.
33. de Haen C, Anelli PL, Lorusso V, et al. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. Invest Radiol. 2006;41:279-291.
34. Simor T, Gaszner B, Oshinski JN, et al. Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart. J Magn Reson Imaging. 2005;21:536-545.
35. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105:224-229.
36. Decking UK, Pai VM, Wen H, et al. Does binding of Gd-DTPA to myocardial tissue contribute to late enhancement in a model of acute myocardial infarction? Magn Reson Med. 2003;49:168-171.
37. Carme S, Mai W, Mazzadi A, et al. Importance of parametric mapping and deconvolution in analyzing MR myocardial perfusion images. Invest Radiol. 2006;41:374-383.